MECP2, a multi-talented modulator of chromatin architecture

Floriana Della Ragione, Marcella Vacca, Salvatore Fioriniello, Giuseppe Pepe, Maurizio D'Esposito

Research output: Contribution to journalArticle

Abstract

It has been a long trip from 1992, the year of the discovery of MECP2, to the present day. What is surprising is that some of the pivotal roles of MeCP2 were already postulated at that time, such as repression of inappropriate expression from repetitive elements and the regulation of pericentric heterochromatin condensation. However, MeCP2 performs many more functions. MeCP2 is a reader of epigenetic information contained in methylated (and hydroxymethylated) DNA, moving from the 'classical' CpG doublet to the more complex view addressed by the non-CpG methylation, which is a feature of the postnatal brain. MECP2 is a transcriptional repressor, although when it forms complexes with the appropriate molecules, it can become a transcriptional activator. For all of these aspects, Rett syndrome, which is caused by MECP2 mutations, is considered a paradigmatic example of a 'chromatin disorder'. Even if the hunt for bona-fide MECP2 target genes is far from concluded today, the role of MeCP2 in the maintenance of chromatin architecture appears to be clearly established. Taking a cue from the non-scientific literature, we can firmly attest that MeCP2 is a player with 'a great future behind it'*.*V. Gassmann 'Un grande avvenire dietro le spalle'. TEA Eds.

Original languageEnglish
Pages (from-to)420-431
Number of pages12
JournalBriefings in Functional Genomics
Volume15
Issue number6
DOIs
Publication statusPublished - Nov 2016

Fingerprint

Modulators
Chromatin
Rett Syndrome
Literature
Methylation
Heterochromatin
Epigenomics
Cues
Condensation
Brain
Genes
Maintenance
Mutation
Molecules
DNA

Keywords

  • Journal Article

Cite this

MECP2, a multi-talented modulator of chromatin architecture. / Della Ragione, Floriana; Vacca, Marcella; Fioriniello, Salvatore; Pepe, Giuseppe; D'Esposito, Maurizio.

In: Briefings in Functional Genomics, Vol. 15, No. 6, 11.2016, p. 420-431.

Research output: Contribution to journalArticle

Della Ragione, Floriana ; Vacca, Marcella ; Fioriniello, Salvatore ; Pepe, Giuseppe ; D'Esposito, Maurizio. / MECP2, a multi-talented modulator of chromatin architecture. In: Briefings in Functional Genomics. 2016 ; Vol. 15, No. 6. pp. 420-431.
@article{2f895fea516b4abba88413d8a17cdfb5,
title = "MECP2, a multi-talented modulator of chromatin architecture",
abstract = "It has been a long trip from 1992, the year of the discovery of MECP2, to the present day. What is surprising is that some of the pivotal roles of MeCP2 were already postulated at that time, such as repression of inappropriate expression from repetitive elements and the regulation of pericentric heterochromatin condensation. However, MeCP2 performs many more functions. MeCP2 is a reader of epigenetic information contained in methylated (and hydroxymethylated) DNA, moving from the 'classical' CpG doublet to the more complex view addressed by the non-CpG methylation, which is a feature of the postnatal brain. MECP2 is a transcriptional repressor, although when it forms complexes with the appropriate molecules, it can become a transcriptional activator. For all of these aspects, Rett syndrome, which is caused by MECP2 mutations, is considered a paradigmatic example of a 'chromatin disorder'. Even if the hunt for bona-fide MECP2 target genes is far from concluded today, the role of MeCP2 in the maintenance of chromatin architecture appears to be clearly established. Taking a cue from the non-scientific literature, we can firmly attest that MeCP2 is a player with 'a great future behind it'*.*V. Gassmann 'Un grande avvenire dietro le spalle'. TEA Eds.",
keywords = "Journal Article",
author = "{Della Ragione}, Floriana and Marcella Vacca and Salvatore Fioriniello and Giuseppe Pepe and Maurizio D'Esposito",
note = "{\circledC} The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.",
year = "2016",
month = "11",
doi = "10.1093/bfgp/elw023",
language = "English",
volume = "15",
pages = "420--431",
journal = "Briefings in Functional Genomics",
issn = "2041-2649",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - MECP2, a multi-talented modulator of chromatin architecture

AU - Della Ragione, Floriana

AU - Vacca, Marcella

AU - Fioriniello, Salvatore

AU - Pepe, Giuseppe

AU - D'Esposito, Maurizio

N1 - © The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

PY - 2016/11

Y1 - 2016/11

N2 - It has been a long trip from 1992, the year of the discovery of MECP2, to the present day. What is surprising is that some of the pivotal roles of MeCP2 were already postulated at that time, such as repression of inappropriate expression from repetitive elements and the regulation of pericentric heterochromatin condensation. However, MeCP2 performs many more functions. MeCP2 is a reader of epigenetic information contained in methylated (and hydroxymethylated) DNA, moving from the 'classical' CpG doublet to the more complex view addressed by the non-CpG methylation, which is a feature of the postnatal brain. MECP2 is a transcriptional repressor, although when it forms complexes with the appropriate molecules, it can become a transcriptional activator. For all of these aspects, Rett syndrome, which is caused by MECP2 mutations, is considered a paradigmatic example of a 'chromatin disorder'. Even if the hunt for bona-fide MECP2 target genes is far from concluded today, the role of MeCP2 in the maintenance of chromatin architecture appears to be clearly established. Taking a cue from the non-scientific literature, we can firmly attest that MeCP2 is a player with 'a great future behind it'*.*V. Gassmann 'Un grande avvenire dietro le spalle'. TEA Eds.

AB - It has been a long trip from 1992, the year of the discovery of MECP2, to the present day. What is surprising is that some of the pivotal roles of MeCP2 were already postulated at that time, such as repression of inappropriate expression from repetitive elements and the regulation of pericentric heterochromatin condensation. However, MeCP2 performs many more functions. MeCP2 is a reader of epigenetic information contained in methylated (and hydroxymethylated) DNA, moving from the 'classical' CpG doublet to the more complex view addressed by the non-CpG methylation, which is a feature of the postnatal brain. MECP2 is a transcriptional repressor, although when it forms complexes with the appropriate molecules, it can become a transcriptional activator. For all of these aspects, Rett syndrome, which is caused by MECP2 mutations, is considered a paradigmatic example of a 'chromatin disorder'. Even if the hunt for bona-fide MECP2 target genes is far from concluded today, the role of MeCP2 in the maintenance of chromatin architecture appears to be clearly established. Taking a cue from the non-scientific literature, we can firmly attest that MeCP2 is a player with 'a great future behind it'*.*V. Gassmann 'Un grande avvenire dietro le spalle'. TEA Eds.

KW - Journal Article

U2 - 10.1093/bfgp/elw023

DO - 10.1093/bfgp/elw023

M3 - Article

C2 - 27296483

VL - 15

SP - 420

EP - 431

JO - Briefings in Functional Genomics

JF - Briefings in Functional Genomics

SN - 2041-2649

IS - 6

ER -